Scarica l'app Stockscreener
31.34
0.63%
-0.20
Dopo l'orario di chiusura:
31.34
Precedente Chiudi:
$31.54
Aprire:
$31.56
Volume 24 ore:
494.41K
Relative Volume:
0.88
Capitalizzazione di mercato:
$1.44B
Reddito:
$1.08B
Utile/perdita netta:
$-20.76M
Rapporto P/E:
-68.13
EPS:
-0.46
Flusso di cassa netto:
$151.63M
1 W Prestazione:
+0.80%
1M Prestazione:
+9.24%
6M Prestazione:
-22.09%
1 anno Prestazione:
-24.84%
Intervallo 1D:
$30.78
$31.80
Intervallo di 1 settimana:
$30.32
$31.88
Portata 52W:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Confronta OMCL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
31.34 | 1.42B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.26B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
5 Must-Read Analyst Questions From Omnicell’s Q2 Earnings Call - Yahoo Finance
Did Strong Q2 Results and Improved Profitability Just Shift Omnicell’s (OMCL) Investment Narrative? - simplywall.st
OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance - ca.finance.yahoo.com
Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - TradingView
Omnicell Inc. Bounces Off Moving Average SupportLow Drawdown Real Time Trading Tips Shared - 선데이타임즈
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $55 - 富途牛牛
Piper Sandler lowers Omnicell stock price target to $55 on tariff concerns - Investing.com Nigeria
Omnicell Inc. recovery potential after sell offFree Weekly Stock Watch With Growth Focus - Newser
Best data tools to analyze Omnicell Inc. stockFree Trade Ready Stock Watch for Short Term - Newser
Does Omnicell Inc. show high probability of reboundPredictive System for Long-Term Stock Forecast - Newser
Intraday pattern recognizer results for Omnicell Inc.Portfolio Booster Strategy with Trend Confidence - Newser
Why Omnicell Inc. stock attracts strong analyst attentionEntry and Exit Strategy for Swing Traders - Newser
Can Omnicell Inc. rally from current levelsTriple Digit Gain Opportunity Watchlist - Newser
What makes Omnicell Inc. stock price move sharplyDaily Pick Forecast with Entry Zones - Newser
Price action breakdown for Omnicell Inc.AI Triggered Buy Zone Forecast System - Newser
Evaluating Omnicell Inc. with trendline analysisHigh Conviction Screener with Trend Matching - Newser
How Investors Are Reacting To Omnicell (OMCL) Q2 Revenue Growth and Raised Full-Year Guidance - simplywall.st
Using R and stats models for Omnicell Inc. forecastingWeekly Stock Movement Prediction Watchlist - Newser
Omnicell 2025 Q2 Earnings Strong Performance as Net Income Surges 51% - AInvest
What moving averages say about Omnicell Inc.Momentum Detection with Entry Optimization - Newser
Omnicell’s Earnings Call Highlights Strong Growth and Strategic Wins - The Globe and Mail
Omnicell Management to Meet with KeyBanc - AInvest
Omnicell's Q2 Earnings Call Highlights Strong Growth, Strategic Wins Amid Challenges - AInvest
Omnicell, Inc. (NASDAQ:OMCL) Q2 2025 Earnings Call Transcript - Insider Monkey
Is This the Dip to Buy in Omnicell Inc.Swing Trading Entry Signals Suggest Opportunity Zone - metal.it
What is Omnicell Inc. company’s growth strategyMaximize gains with proven stock analysis - Jammu Links News
What analysts say about Omnicell Inc. stockMassive profits - Jammu Links News
Omnicell Inc. Stock Analysis and ForecastInvest smarter with actionable market insights - Jammu Links News
What are the latest earnings results for Omnicell Inc.Get insider insights into market trends - Jammu Links News
Is Omnicell Inc. a growth stock or a value stockAchieve consistent profits with expert strategies - Jammu Links News
When is Omnicell Inc. stock expected to show significant growthBuild a portfolio for long-term financial success - Jammu Links News
Is it the right time to buy Omnicell Inc. stockInvest smarter with actionable trading signals - Jammu Links News
Omnicell, Inc. (NASDAQ:OMCL) Shares Purchased by XTX Topco Ltd - Defense World
How does Omnicell Inc. compare to its industry peersDouble-digit growth - jammulinksnews.com
What earnings revisions data tells us about Omnicell Inc.RSI and MACD Signal Summary with Trends - Newser
Why is Omnicell Inc. stock attracting strong analyst attentionTremendous return rates - Jammu Links News
What is the dividend policy of Omnicell Inc. stockCapitalize on emerging investment opportunities - Jammu Links News
What markets is SEAL.PRB expanding into Is Omnicell Inc. stock a good long term investment optionAchieve consistent high returns with low risk - Jammu Links News
How strong is Omnicell Inc. company’s balance sheetExceptional financial outcomes - Jammu Links News
Omnicell's Q2 2025 Earnings Highlight Resilience and Growth in Healthcare Automation - AInvest
Omnicell's Q2 2025 Earnings Outperformance: A Strategic Case for Capitalizing on a Resilient Medical Tech Innovator - AInvest
Omnicell Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Arkadios Wealth Advisors Boosts Holdings in Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell's Financial Performance and Growth Prospects Support Buy Rating - AInvest
Omnicell's Strategic Shift to Recurring Revenue: A Pathway to Sustainable Growth in 2025 - AInvest
Omnicell's Q2 2025 Earnings and Strategic Edge in the Autonomous Pharmacy Market: A Case for Long-Term Growth - AInvest
Omnicell, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:OMCL) - Seeking Alpha
Pharmacy Automation Market: Strategic Growth, Competitive Landscape & Long-Term Value for Healthcare Leaders - Barchart.com
What are analysts’ price targets for Omnicell Inc. in the next 12 monthsExpert Picks Outlook From AI Tools - Jammu Links News
Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High? - Yahoo Finance
Federated Hermes Inc. Sells 41,248 Shares of Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Omnicell Inc Azioni (OMCL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
11.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):